Evidence map›Paper›PMID 27226537›Full record

ArticleThe Journal of biological chemistry2016

Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.

Line Barington, Pia C Rummel, Michael Lückmann, Heidi Pihl, Olav Larsen, Viktorija Daugvilaite, Anders H Johnsen, Thomas M Frimurer, Stefanie Karlshøj, Mette M Rosenkilde

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Line BaringtonFrom the Department of Neuroscience and Pharmacology.
Pia C RummelFrom the Department of Neuroscience and Pharmacology.
Michael LückmannFrom the Department of Neuroscience and Pharmacology, the Novo Nordisk Foundation Center for Basic Metabolic Research, and.
Heidi PihlFrom the Department of Neuroscience and Pharmacology.
Olav LarsenFrom the Department of Neuroscience and Pharmacology.
Viktorija DaugvilaiteFrom the Department of Neuroscience and Pharmacology.
Anders H Johnsenthe Department of Clinical Biochemistry, Rigshospitalet, DK-2100 Copenhagen, Denmark.
Thomas M Frimurerthe Novo Nordisk Foundation Center for Basic Metabolic Research, and the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, DK-2200 Copenhagen, Denmark and.
Stefanie KarlshøjFrom the Department of Neuroscience and Pharmacology.
Mette M RosenkildeFrom the Department of Neuroscience and Pharmacology, rosenkilde@sund.ku.dk.
University of Copenhagen · DKNovo Nordisk Foundation · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokine receptors play important roles in the immune system and are linked to several human diseases. The initial contact of chemokines with their receptors depends on highly specified extracellular receptor features. Here we investigate the importance of conserved extracellular disulfide bridges and aromatic residues in extracellular loop 2 (ECL-2) for ligand binding and activation in the chemokine receptor CCR8. We used inositol 1,4,5-trisphosphate accumulation and radioligand binding experiments to determine the impact of receptor mutagenesis on both chemokine and small molecule agonist and antagonist binding and action in CCR8. We find that the seven-transmembrane (TM) receptor conserved disulfide bridge (7TM bridge) linking transmembrane helix III (TMIII) and ECL-2 is crucial for chemokine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between the N terminus and TMVII is needed only for chemokines. Furthermore, we find that two distinct aromatic residues in ECL-2, Tyr(184) (Cys + 1) and Tyr(187) (Cys + 4), are crucial for binding of the CC chemokines CCL1 (agonist) and MC148 (antagonist), respectively, but not for small molecule binding. Finally, using in silico modeling, we predict an aromatic cluster of interaction partners for Tyr(187) in TMIV (Phe(171)) and TMV (Trp(194)). We show in vitro that these residues are crucial for the binding and action of MC148, thus supporting their participation in an aromatic cluster with Tyr(187) This aromatic cluster appears to be present in a large number of CC chemokine receptors and thereby could play a more general role to be exploited in future drug development targeting these receptors.

Indexed as

AnimalsChemokine CCL1Chemokines, CCChlorocebus aethiopsCOS CellsDisulfidesHumansInositol 1,4,5-TrisphosphateProtein BindingProtein DomainsProtein Structure, SecondaryReceptors, CCR8Viral ProteinsCCL1 protein, humanCCR8 protein, humanChemokine CCL1Chemokines, CCDisulfidesInositol 1,4,5-TrisphosphateMC148 protein, poxvirus molluscum contagiosumReceptors, CCR8Viral ProteinsCCR8chemokine receptorG protein-coupled receptor (GPCR)metal ion-protein interactionmolecular pharmacologymutagenesis in vitroprotein-protein interactionreceptor structure-function

Identifiers

PMID27226537
PMCPMC4965569
OpenAlexW2406715792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.